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a  b  s  t  r  a  c  t
Preterm  birth  (PTB)  is the  leading  cause  of childhood  mortality  in  children  under  5 and  accounts  for
approximately  11% of  births  worldwide.  Premature  babies  are  at risk  of a number  of health  complications,
notably  cerebral  palsy,  but also  respiratory  and  gastrointestinal  disorders.  Preterm  deliveries  can  be
medically  indicated/elective  procedures  or  they  can  occur  spontaneously.  Spontaneous  PTB  is commonlyeywords:
reterm birth
nﬂammation
etal injury
associated  with  intrauterine  infection/inﬂammation.  The  presence  of  inﬂammatory  mediators  in utero
has  been  associated  with  fetal  injury,  particularly  affecting  the  fetal  lungs  and  brain.  This review  will
outline  (i)  the  role of  inﬂammation  in  term  and  PTB, (ii)  the  effect  infection/inﬂammation  has  on  fetal
development  and  (iii)  recent  strategies  to  target  PTB. Further  research  is  urgently  required to develop
effective  methods  for  the  prevention  and  treatment  of  PTB  and  above  all,  to  reduce  fetal  injury.
© 2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC. Introduction
The World Health Organisation deﬁnes preterm birth (PTB) as
elivery before 37 completed weeks of gestation. PTB can be sub-
ivided into extremely preterm (<28 weeks), very preterm (28–32
eeks) and moderate to late PTB (32–36 weeks) (WHO, 1977). In
010, 14.9 million babies were born preterm, accounting for 11.1%
f all births worldwide. Rates of PTB range from approximately 5%
f births in European countries, to 18% in certain African countries
Blencowe et al., 2012). PTB is currently the leading cause of child-
ood mortality in children under 5 years (Harrison and Goldenberg,
015). The economic burden of PTB to the public sector is estimated
o be >£2.9 billion (Mangham et al., 2009). Much of the economic
urden can be attributed to neonatal intensive care, often followed
y ongoing health care and educational requirements, in addition
o the emotional impact experienced by families (Howson et al.,
013).
PTB can be medically indicated/iatrogenic or spontaneous. Med-
cally indicated PTB accounts for approximately a third of PTBs
n high income countries (Rubens et al., 2014). This occurs when
he risk to the fetus or mother outweighs the beneﬁt of continu-
ng the pregnancy, for instance in conditions such as preeclampsia
nd diabetes. Approximately 70% of PTBs are spontaneous, with
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women presenting with preterm labour (PTL) with cervical dila-
tion or preterm premature rupture of membranes (Rubens et al.,
2014).
PTL can be initiated by multiple mechanisms, including infection
or inﬂammation, uteroplacental ischaemia or haemorrhage, uter-
ine overdistension or stress (Goldenberg et al., 2008; Romero et al.,
1994). Maternal risk factors include extremes in maternal age, body
mass index (BMI), multiple gestation, the use of assisted repro-
ductive technologies, history of PTB and low socioeconomic status
(Rubens et al., 2014). Race is also an important risk factor, with
women classiﬁed as black, African-American or Afro-Caribbean at
greater risk of PTB than other ethnic groups (Goldenberg et al.,
2008).
Due to the immaturity of multiple organ systems, premature
newborns are at risk of a number of health complications (Rubens
et al., 2014). As you would expect, the severity of complications
inversely correlates with gestational age (WHO, 1977). Children
born prematurely have an increased risk of cognitive and neurolog-
ical impairment such as cerebral palsy, as well as respiratory and
gastrointestinal complications (Goldenberg et al., 2008; Marlow
et al., 2005). There is also the increased risk of chronic diseases
in adulthood, such as obesity, diabetes and hypertension (Rubens
et al., 2014). Interestingly, neonatal outcomes are sex-speciﬁc. Pre-
mature males are at greater risk of morbidity and mortality than
females. In one premature cohort, the males had poorer neurolog-
ical and respiratory outcomes, when followed up at 2 years of age
(Peacock et al., 2012).
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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. Inﬂammation in labour and preterm labour
Human parturition is an inﬂammatory process (Bollapragada
t al., 2009). Labour is initiated by the shift from a quiescent to
 pro-inﬂammatory environment, instigating a three step process,
haracterised by uterine contractility, cervical ripening and mem-
rane activation/rupture (Rinaldi et al., 2011; Romero et al., 1994).
ytokines are essential in the initiation and regulation of this pro-
ess (Bowen et al., 2002).
Monocytes and neutrophils are primed in the peripheral blood
n association with both term and PTL (Yuan et al., 2009). These
ells inﬁltrate the human myometrium and cervix during sponta-
eous term labour, which is associated with a signiﬁcant increase in
nterleukin (IL)-1ˇ, IL-6 and IL-8 gene expression (Bokstrom et al.,
997; Osman et al., 2003; Thomson et al., 1999). Stromal cells of
he maternal and fetal tissues are also responsible for the release
f pro-inﬂammatory cytokines such as IL-1, IL-6, IL-8 and tumour
ecrosis factor alpha (TNF) (Young et al., 2002). Myometrial con-
ractions are stimulated by the increase of IL-1 and TNF, which
ncrease calcium entry into these myometrial smooth muscle cells
Barata et al., 2004; Tribe et al., 2003). Prostaglandins, PGF2 and
GE2 are also involved in the stimulation of myometrial contrac-
ions (Olson, 2003). Cervical ripening is an inﬂammatory event in
oth term and PTB (Osman et al., 2003; Tornblom et al., 2005).
ro-inﬂammatory cytokines stimulate matrix metalloproteinase
MMP)  expression, such as MMP-9, which promotes extracellular
atrix degradation and cervical remodelling (Larsen and Hwang,
011).
There is also a signiﬁcant increase in leukocyte recruitment to
he fetal membranes during parturition, with an increase in IL-1,
L-8, and TNF (Gomez-Lopez et al., 2009). Normal and preterm
upture of membranes differ in regional chemotactic activity and
elated chemokine/cytokine production, which may  suggest dif-
erential mechanisms of rupture (Gomez-Lopez et al., 2013). The
horiodecidua is responsible for granulocyte, T-cell lymphocyte,
onocyte and NK cells chemoattraction (Gomez-Lopez et al., 2011).
eukocytes inﬁltrate the decidua during labour at term and in PTL
nd play a role in stimulating inﬂammatory mediators involved
n decidual activation (Hamilton et al., 2012; Osman et al., 2003).
acrophage numbers are increased in term and PTL but neutrophil
bundance is only signiﬁcantly increased in the decidua in PTL with
nfection (Hamilton et al., 2012).
Nuclear factor-B (NF-B) is a pleiotropic transcription factor
hich is commonly associated with inﬂammation, as it is acti-
ated by and regulates pro-inﬂammatory cytokines. NF-B activity
s central to labour-associated pathways. It is required for both
rostaglandin synthesis and for the regulation of MMP  expression
nd thus, important for the stimulation of uterine contractions and
ervical ripening. The premature or pathological activation of NF-
B could subsequently contribute to the initiation of PTL (Lindstrom
nd Bennett, 2005).
. Fetal injury
Intrauterine infection/inﬂammation is a common cause of PTL.
resence of such an adverse in utero environment can lead to fetal
njury. Chorioamnionitis, characterised by inﬂammation of the fetal
embranes as a result of bacterial infection, is a risk factor for con-
itions such as cerebral palsy, necrotising enterocolitis and patent
uctus arteriosus (Been et al., 2013; Park et al., 2015; Wu and
olford, 2000). Bacteria or inﬂammatory mediators may  reach the
etal circulation by placental transmission into the umbilical cord
r indirectly via the amniotic ﬂuid, resulting in fetal injury (Adams
aldorf and Mcadams, 2013) (Fig. 1).e Immunology 119 (2017) 62–66 63
Intra-amniotic inﬂammation is also associated with lung injury.
Elevated levels of inﬂammatory mediators such as TNF-, IL-1,
IL-6 and IL-8 in the amniotic ﬂuid have been found in women who
had babies with bronchopulmonary dysplasia (BPD), a chronic lung
disease affecting infants (Ambalavanan et al., 2011; Yoon et al.,
1997b). However, a meta-analysis found only a modest association
between chorioamnionitis and BPD (Hartling et al., 2012). Intra-
amniotic endotoxin administration in a sheep model led to fetal
lung injury, identiﬁed by evidence of inﬂammation, cell death and
remodelling (Kramer et al., 2002). Exposure to endotoxin in utero
also affects the development of the fetal ovine lung. One study
observed an increase in alveolar volume, while the total number of
alveolar was  signiﬁcantly reduced. Thinning of the alveolar walls
was also observed (Willet et al., 2000). In a chronically catheterised
sheep model of the extreme preterm period, lipopolysaccharide
(LPS) exposure caused fetal skin and lung inﬂammation, as well as
systemic inﬂammation (Kemp, 2014; Kemp et al., 2016). The pre-
mature fetus rapidly generated a robust inﬂammatory response to
intra-amniotic LPS, which was driven by amniotic ﬂuid-exposed
tissues. Fetal blood cells responded to systemic inﬂammation but
didn’t contribute to the acute production of inﬂammatory media-
tors (Kemp et al., 2016). Furthermore, a primate model of transient
choriodecidual infection conﬁrmed indirect lung injury as result of
elevated inﬂammatory mediators. This led to the downregulation of
pathways for angiogenesis, morphogenesis and cellular growth and
development in the fetal lung (Mcadams et al., 2012). In addition to
conditions such as neonatal BPD, the treatment premature babies
receive can have an adverse effect on pulmonary development and
lead to long term, altered lung function. A follow up study reported
evidence of airway obstruction from mid-childhood to adulthood
in a preterm-born cohort (Vollsaeter et al., 2013).
Prematurity has also been associated with an increased inci-
dence of brain damage. This can result in neurological conditions
such as cerebral palsy, which is often observed in conjunction
with intraventricular haemorrhage or periventricular leukomalacia
(Chang, 2015). Additionally, inﬂammation during fetal and neona-
tal development has been linked to other neuropathologies such as
schizophrenia and autism. It has been suggested that schizophre-
nia may  be as a result of post-acute latent inﬂammation, whereas
autism may  be due to persistent inﬂammation (Meyer et al., 2011).
The release of pro-inﬂammatory mediators can play a role in
the generation of brain white matter lesions. Evidence of elevated
levels of IL-1 and IL-6 in the amniotic ﬂuid has been used to iden-
tify premature newborns at risk of developing these lesions (Yoon
et al., 1997a). TNF signalling, in particular, has been described as
toxic to developing oligodendrocytes (Li et al., 2008). The isolation
of low-virulence microorganisms from preterm placentas, such as
common skin microﬂora, has been associated with brain lesions and
cerebral palsy in these infants. Evidence of placental inﬂammation
alone, is a predictor of brain injury (Leviton et al., 2010). Even in the
absence of PTB, fetal brain injury was  reported in a mouse model
of intrauterine inﬂammation (Elovitz et al., 2011). The same group
reported damage to fetal neurons, demonstrated by a signiﬁcant
reduction in microtubule-associated protein 2 (Map2)  gene expres-
sion, as well as altered neuronal morphology and neurotoxicity, in
this model (Burd et al., 2011). Dada et al. (2014) found that follow-
ing intrauterine inﬂammation, brain injury is not only acute. Long
term changes in MRI  and behaviour are observed even in adult-
hood. Chronic brain inﬂammation was linked to eventual neuronal
loss. In addition, these effects were found to be sex speciﬁc, with
male mice more susceptible to long-term neurologic injury. Mallard
et al. (2003) exposed fetal sheep to LPS during mid-gestation and
reported microglia activation, astrocyte damage and oligodendro-
cyte death. Inﬂammation may  cause brain injury as a result of direct
insult to oligodendrocytes and neurons or as secondary injury via
microglial cell activation. This subsequently results in the secretion
64 A.K. Boyle et al. / Journal of Reproductive Immunology 119 (2017) 62–66
Fig. 1. Intrauterine inﬂammation and fetal injury.
Human parturition is an inﬂammatory process. However, the presence of inﬂammation earlier in gestation can result in the preterm, pathological initiation of labour, with
adverse  consequences for the fetus. Inﬂammatory mediators may reach the fetal circulation by placental transmission into the umbilical cord or indirectly via the amniotic
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s  cerebral palsy and autism.
f pro-inﬂammatory cytokines, causing damage to surrounding
ells (Burd et al., 2012).
. Prevention and treatment of PTL
In general, tocolytic therapies are largely ineffective at substan-
ially delaying delivery and reducing neonatal mortality (Haas et al.,
012). Several trials have reported the beneﬁts of vaginal proges-
erone administration for reducing the rates of PTB and improving
eonatal outcome. However, these studies had limited information
n the long term outcome of these infants (Da Fonseca et al., 2003;
odd et al., 2013; Fonseca et al., 2007; Hassan et al., 2011). Recently,
 large, double-blind, randomised, placebo controlled trial of vagi-
al progesterone treatment reported that the risk of PTB was not
educed by progesterone nor was neonatal outcome improved, in
omen who were at risk of PTB. The trial did not ﬁnd any long term
eneﬁt of this treatment in children by the time they were 2 years
f age (Norman et al., 2016).
As intrauterine infection is a common cause of PTL, antibiotics
ave previously been considered a logical method of treatment.
owever, the use of antibiotics to prevent PTB has been associ-
ted with neonatal enterocolitis, as well as an increased risk ofﬂammatory response. Prolonged in utero exposure to inﬂammatory mediators can
lasia (BPD), as well as brain white matter lesions and neurological conditions such
cerebral palsy (Kenyon et al., 2001; Kenyon et al., 2008). As par-
turition is associated with leukocyte inﬂux into the intrauterine
tissues, immunomodulation has been investigated in mouse mod-
els of PTB, using leukocyte depletion. Rinaldi et al. (2014) found that
neutrophil depletion did not delay delivery in an LPS-mediated PTB
mouse model, despite having an important role in the inﬂamma-
tory response in the intrauterine tissues. Filipovich et al. (2015)
further corroborated this ﬁnding by reporting that polymorphonu-
clear leukocyte depletion in an E. coli model of PTB did not prevent
premature birth. Therefore, neutrophil inﬁltration is not essen-
tial for the induction of murine infection-induced PTB. However,
macrophage depletion was found to successfully prevent both
RU486 and LPS-induced PTB in mice (Gonzalez et al., 2011).
Targeting the inﬂammation commonly associated with PTB may
be a suitable approach to delay the onset of parturition and pre-
vent fetal injury. A recent review outlined the possible targets for
such treatments including non-speciﬁc NF-kB inhibitors, toll-like
receptor 4 (TLR4) antagonists, TNF biologics and novel cytokine
suppressive anti-inﬂammatory drugs (CSAIDs) (Ng et al., 2015;
Stinson et al., 2014). Shynlova et al. (2014) targeted the activiation
of murine peripheral maternal immune cells with a broad spec-
trum chemokine inhibitor. A reduced incidence of LPS-induced PTB
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as reported, in additon to reducing both immune cell inﬁltra-
ion into maternal tissues and inﬂammatory mediator secretion.
ther novel, naturally produced or alternative therapies such as
olic acid, melatonin and statins, have recently been investigated
or the treatment of PTB and fetal loss in mouse models (Boyle
t al., 2015; Dominguez Rubio et al., 2014; Gonzalez et al., 2014;
hao et al., 2013). Antigen capture therapy has been described in an
vine model of intrauterine infection/inﬂammation. This cationic
eptide antibiotic, polymyxin B, binds to E. coli, reducing inﬂamma-
ion in the amniotic ﬂuid and fetal lung (Saito et al., 2014). Rinaldi
t al. (2015) investigated the use of a key anti-inﬂammatory and
ro-resolution mediator, 15-epi-lipoxin A4, in an LPS-induced PTB
ouse model. Although PTB was not prevented, 15-epi-lipoxin A4
educed rates of fetal death.
It is unlikely that one treatment will be successful in preventing
he multifactorial syndrome of PTB. However, it should be consid-
red that combination therapies, which have both tocolytic and
etal protective effects, would be advantagous. Improved meth-
ds of identifying at risk mothers and fetuses are also required to
ffectively target treatments and avoid unnecessary harm. Using
ew ultrasound techniques, such as Tissue Doppler Imaging (TDI),
o identify signs of fetal inﬂammation is one strategy that shows
romise (Di Naro et al., 2010; Stock et al., 2016). The inﬂuence
enotype may  have on the therapeutics used for PTB prevention
nd treatment, has recently been discussed. Although the evidence
o date is limited, there is increasing indication that pharmacoge-
omics may  play a role in PTB. By integrating clinical information,
nvironmental inﬂuences and genotype, a more comprehensive
trategy to personalised medicine could be optimised (Manuck,
016).
. Conclusion
PTB is still a signiﬁcant public health problem. This syndrome
s multifactorial and its etiology is not well understood. Inﬂamma-
ion is necessary to stimulate term labour. However, its presence
arlier in pregnancy contributes to fetal injury, particularly to the
ung and brain. Evidence of inﬂammatory mediators in the amni-
tic ﬂuid identiﬁes infants at risk of lung damage and brain white
atter lesions. Delaying PTB, as well as improving the outcome of
he babies, has proved a great challenge. Current therapies, such as
aginal progesterone treatment, are ineffective. In addition, the use
f antibiotics to target intrauterine infection is potentially harmful
o the developing fetus, increasing the risk of cerebral palsy. Animal
odels are currently being utilised to investigate potential thera-
eutic agents which may  target the intrauterine inﬂammation with
he intention of protecting against fetal injury. The possibility of
eveloping more personalised medicine should also be considered
n the effort to reduce the rates of fetal mortality and morbidity, as
 result of this clinical condition.
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